Cardiovascular system medicine sales in Spain have shown a clear downward trend from 2013 to 2023, with a significant decline noted especially from 2017 onward. In 2023, the total sales stood at 10.3 units. Year-on-year variations from 2022 to 2023 indicated a decrease of 7.21%, and the 5-year CAGR from 2018 to 2023 was -3.17%. The forecast suggests a continued decline with a forecast 5-year CAGR of -7.22%, projecting a 31.25% reduction by 2028.

Future trends to watch for:

Potential impact of new cardiovascular innovations or generic drugs entering the market
Changes in healthcare policies or reimbursement structures in Spain
Shifts in population demographics, notably aging population trends and lifestyle-related risk factors